Excitatory Amino Acid Antagonists [Pharmacological Action]
Tree Number(s): D018691
MeSH Unique ID: D018691
- 2-amino-3-phosphonopropionic acid (Supplementary Concept)
- caroverine (Supplementary Concept)
- 1-hydroxy-3-amino-2-pyrrolidone (Supplementary Concept)
- ifenprodil (Supplementary Concept)
- glutamic acid diethyl ester (Supplementary Concept)
- ketobemidone (Supplementary Concept)
- 2,3-piperidinedicarboxylic acid (Supplementary Concept)
- 2-amino-7-phosphonoheptanoic acid (Supplementary Concept)
- carbinoxamine, dextromethorphan, pseudoephedrine drug combination (Supplementary Concept)
- 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (Supplementary Concept)
- selfotel (Supplementary Concept)
- conotoxin GV (Supplementary Concept)
- FG 9041 (Supplementary Concept)
- 7-chlorokynurenic acid (Supplementary Concept)
- eliprodil (Supplementary Concept)
- NPC 12626 (Supplementary Concept)
- GYKI 52466 (Supplementary Concept)
- HU 211 (Supplementary Concept)
- 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (Supplementary Concept)
- conantokin-T (Supplementary Concept)
- 2-amino-4-methyl-5-phosphono-3-pentenoic acid (Supplementary Concept)
- CGP 39551 (Supplementary Concept)
- SDZ EAA 494 (Supplementary Concept)
- 5,7-dichlorokynurenic acid (Supplementary Concept)
- CGP 39653 (Supplementary Concept)
- gacyclidine (Supplementary Concept)
- 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline (Supplementary Concept)
- 3,5-dihydroxyphenylglycine (Supplementary Concept)
- GYKI 53655 (Supplementary Concept)
- 4-carboxyphenylglycine (Supplementary Concept)
- alpha-methyl-4-carboxyphenylglycine (Supplementary Concept)
- aptiganel (Supplementary Concept)
- 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (Supplementary Concept)
- LY 235959 (Supplementary Concept)
- licostinel (Supplementary Concept)
- L 701324 (Supplementary Concept)
- 1-aminoindan-1,5-dicarboxylic acid (Supplementary Concept)
- 3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid (Supplementary Concept)
- LY 341495 (Supplementary Concept)
- 6-methyl-2-(phenylethynyl)pyridine (Supplementary Concept)
- kaitocephalin (Supplementary Concept)
- 2-amino-3-((3,4-difluorophenyl)sulfanylmethyl)-4-hydroxy-bicyclo(3.1.0)hexane-2,6-dicarboxylic acid hydrochloride (Supplementary Concept)
- 2-Oxo-PCE (Supplementary Concept)
- 2-(1,1-dimethyl-1,3-dihydro-benzo(e)indol-2-ylidene)-malonaldehyde (Supplementary Concept)
- BCI-838 (Supplementary Concept)
- Dextromethorphan (MeSH Term)
- Dextrorphan (MeSH Term)
- Ibogaine (MeSH Term)
- Ketamine (MeSH Term)
- Kynurenic Acid (MeSH Term)
- Memantine (MeSH Term)
- Phencyclidine (MeSH Term)
- Phenobarbital (MeSH Term)
- 2-Aminoadipic Acid (MeSH Term)
- 2-Amino-5-phosphonovalerate (MeSH Term)
- Dizocilpine Maleate (MeSH Term)
- 6-Cyano-7-nitroquinoxaline-2,3-dione (MeSH Term)
- Riluzole (MeSH Term)
- Gabapentin (MeSH Term)
- Felbamate (MeSH Term)